|
Originally published In Press as doi:10.1074/jbc.M104882200 on August 31, 2001
J. Biol. Chem., Vol. 276, Issue 44, 40497-40501, November 2, 2001
Anti-atherogenic Antioxidants Regulate the Expression and
Function of Proteasome -Type Subunits in Human Endothelial
Cells*
Wakako
Takabe ,
Tatsuhiko
Kodama ,
Takao
Hamakubo ,
Keiji
Tanaka§,
Toshiaki
Suzuki§,
Hiroyuki
Aburatani¶,
Naeko
Matsukawa¶, and
Noriko
Noguchi¶
From the Department of Molecular Biology and
Medicine, Research Center for Advanced Science and Technology,
University of Tokyo, 4-6-1 Komaba, Meguro, Tokyo 153-8904, Japan, the
§ Tokyo Metropolitan Institute of Medical Science and CREST,
Japan Science and Technology Corporation, 3-18-22 Komagome, Bunkyo,
Tokyo 113-8613, Japan, and ¶ Genome Sciences, Research Center for
Advanced Science and Technology, University of Tokyo, 4-6-1 Komaba,
Meguro, Tokyo 153-8904, Japan
It has been proposed that phenolic antioxidants
such as probucol exert their anti-atherogenic effects through
scavenging lipid-derived radicals. In this study the potential for
genomics to reveal unanticipated pharmacological properties of phenolic
antioxidants is explored. It was found that two anti-atherogenic
compounds, BO-653 and probucol, inhibited the expression of three
-type proteasome subunits, PMSA2, PMSA3, and PMSA4 in human
umbilical vein endothelial cells. Here we report that both BO-653 and
probucol caused not only inhibition of the mRNA levels of these
three subunits but also inhibition of both the gene expression and
protein synthesis of the -type subunit, PMSA1. Other subunit
components of the proteasome such as the -type subunits (PMSB1,
PMSB7), the ATPase subunit of 19 S (PMSC6), the non-ATPase subunit of
19 S (PMSD1), and PA28 (PMSE2) were not significantly affected by
treatment with these compounds. The specific inhibition of -type
subunit expression in response to these antioxidants resulted in
functional alterations of the proteasome with suppression of
degradation of multiubiquitinated proteins and I B .
These results suggest that certain compounds previously
classified solely as antioxidants are able to exert potentially
important modulatory effects on proteasome function.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Genome
Sciences, Research Center for Advanced Science and Technology, The
University of Tokyo, 4-6-1 Komaba, Meguro, Tokyo 153-8904, Japan. Tel.:
81-3-5452-5356; Fax: 81-3-5452-5359; E-mail:
nonoriko@oxygen.rcast.u-tokyo.ac.jp.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B.-Y. Kang, S. Tsoi, Shan Zhu, Shenghui Su, and H. H. Kay
Differential Gene Expression Profiling in HELLP Syndrome Placentas
Reproductive Sciences,
March 1, 2008;
15(3):
285 - 294.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Herrmann, L. O. Lerman, and A. Lerman
Ubiquitin and Ubiquitin-Like Proteins in Protein Regulation
Circ. Res.,
May 11, 2007;
100(9):
1276 - 1291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Watanabe, J. W. Zmijewski, W. Takabe, M. Umezu-Goto, C. L. Goffe, A. Sekine, A. Landar, A. Watanabe, J. Aoki, H. Arai, et al.
Activation of Mitogen-Activated Protein Kinases by Lysophosphatidylcholine-Induced Mitochondrial Reactive Oxygen Species Generation in Endothelial Cells
Am. J. Pathol.,
May 1, 2006;
168(5):
1737 - 1748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-i. Hirano, C. Ikegami, K.-i. Tsujii, Z. Zhang, F. Matsuura, Y. Nakagawa-Toyama, M. Koseki, D. Masuda, T. Maruyama, I. Shimomura, et al.
Probucol Enhances the Expression of Human Hepatic Scavenger Receptor Class B Type I, Possibly Through a Species-Specific Mechanism
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2005;
25(11):
2422 - 2427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-K. Kwak, N. Wakabayashi, J. L. Greenlaw, M. Yamamoto, and T. W. Kensler
Antioxidants Enhance Mammalian Proteasome Expression through the Keap1-Nrf2 Signaling Pathway
Mol. Cell. Biol.,
December 1, 2003;
23(23):
8786 - 8794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Braun, S. Zhang, H. E. Miettinen, S. Ebrahim, T. M. Holm, E. Vasile, M. J. Post, D. M. Yoerger, M. H. Picard, J. L. Krieger, et al.
Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse
PNAS,
June 10, 2003;
100(12):
7283 - 7288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Goldberg, C. I. Whiteside, and I. G. Fantus
The Hexosamine Pathway Regulates the Plasminogen Activator Inhibitor-1 Gene Promoter and Sp1 Transcriptional Activation through Protein Kinase C-beta I and -delta
J. Biol. Chem.,
September 6, 2002;
277(37):
33833 - 33841.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|